GSA CAPITAL PARTNERS LLP - IDERA PHARMACEUTICALS INC ownership

IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 57 filers reported holding IDERA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$241,000
-8.0%
83,405
-15.2%
0.03%
+13.8%
Q2 2019$262,000
+56.9%
98,309
+50.2%
0.03%
+70.6%
Q1 2019$167,00065,4480.02%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Broadfin Capital, LLC 629,340$5,607,0000.82%
Baker Brothers Advisors 4,833,897$43,070,0000.28%
Kassirer Asset Management Corp 19,341$172,0000.11%
Virtus ETF Advisers LLC 34,596$308,0000.03%
Palo Alto Investors LP 77,044$686,0000.03%
OXFORD ASSET MANAGEMENT LLP 147,560$1,280,0000.03%
ROPES WEALTH ADVISORS LLC 12,500$111,0000.03%
Candriam S.C.A. 195,000$1,737,0000.02%
NATIXIS 429,816$3,830,0000.02%
Cordasco Financial Network 1,875$17,0000.02%
View complete list of IDERA PHARMACEUTICALS INC shareholders